NCT04107207View on ClinicalTrials.gov

Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

May 20, 2020

Study Completion Date

July 1, 2020

Conditions
Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Ginger Kombucha

Craft Ginger Kombucha, a fermented black tea

DIETARY_SUPPLEMENT

Ginger Water

Placebo

Trial Locations (1)

20007

Georgetown University MedStar Hospital, Washington D.C.

All Listed Sponsors
lead

Georgetown University

OTHER

NCT04107207 - Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects | Biotech Hunter | Biotech Hunter